July, 2015 | The Wall Street Analyzer

Latest News

[ June 10, 2021 ] Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US News Feed
[ June 9, 2021 ] GOLDEN INDEPENDENCE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING News Feed
[ June 4, 2021 ] Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules News Feed
[ June 4, 2021 ] City View Green Holdings Inc. and Budd Hutt Inc. Open Second Retail Cannabis Store in Grande Cache, Alberta News Feed
[ June 3, 2021 ] Golden Independence Announces Private Placement Financing News Feed
[ May 26, 2021 ] Citius Pharmaceuticals Selected to Receive Best Poster Award at the International Society for Cell and Gene Therapy 2021 Annual Meeting News Feed
[ May 19, 2021 ] Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia News Feed

Farmland Partners Inc (NYSE:FPI) CEO Interview

July 31, 2015 The Wall Street Analyzer Comments Off

Interview with CEO Paul Pittman […]

DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview

July 30, 2015 The Wall Street Analyzer Comments Off

Interview with Jeff Bacha, CEO […]

OCI Partners LP Schedules 2015 Second Quarter Results Conference Call

July 30, 2015 The Wall Street Analyzer Comments Off

NYSE:OCIP […]

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

July 30, 2015 The Wall Street Analyzer Comments Off

Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing.

Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]

Viveve Medical, Inc. (OTCQB:VIVMF) CEO Interview

July 28, 2015 The Wall Street Analyzer Comments Off

Interview with CEO Patricia Scheller […]

Karnalyte Resources (TSX:KRN) CEO Interview

July 22, 2015 The Wall Street Analyzer Comments Off

Interview with Robin Phinney, CEO […]

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

July 20, 2015 The Wall Street Analyzer Comments Off

NASDAQ:EDUC […]

Pieris Pharma (NASDAQ:PIRS) CEO Interview

July 20, 2015 The Wall Street Analyzer Comments Off

Interview with Steve Yoder, CEO […]

Immune Pharmaceuticals Joins The Russell Microcap Index

July 20, 2015 The Wall Street Analyzer Comments Off

NASDAQ:IMNP […]

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

July 20, 2015 The Wall Street Analyzer Comments Off

Will Also Participate in Additional Wattenberg Well […]

Month: July 2015

Farmland Partners Inc (NYSE:FPI) CEO Interview

DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview

OCI Partners LP Schedules 2015 Second Quarter Results Conference Call

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

Viveve Medical, Inc. (OTCQB:VIVMF) CEO Interview

Karnalyte Resources (TSX:KRN) CEO Interview

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

Pieris Pharma (NASDAQ:PIRS) CEO Interview

Immune Pharmaceuticals Joins The Russell Microcap Index

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

Client Testimonials: